CD44 and cancer: IL-15 mDCs also showed higher stimulatory capacity regarding autologous T cells, a higher proportion of CD44+ and IFN-γ+ in CD4+ and CD8+ T cells, and higher cytotoxicity of T cells against cancer cell lines and patient autologous primary myeloma cells.